We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+0.75%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.34B
AUM Growth
-$123M
Cap. Flow
-$153M
Cap. Flow %
-11.43%
Top 10 Hldgs %
26.37%
Holding
215
New
22
Increased
46
Reduced
51
Closed
31

Top Buys

Rank Stock Value
1
IMCR icon
Immunocore
IMCR
+$30.1M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$21.3M
3
BWXT icon
BWX Technologies
BWXT
+$17.1M
4
CBAY
Cymabay Therapeutics
CBAY
+$15.2M
5
IMGN
Immunogen Inc
IMGN
+$14M

Top Sells

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$37.8M
2
INSP icon
Inspire Medical Systems
INSP
+$37.4M
3
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$35.7M
4
DICE
DICE Therapeutics, Inc. Common Stock
DICE
+$19.3M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 52.08%
2 Technology 13.86%
3 Industrials 8.87%
4 Energy 5.36%
5 Financials 5.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CXT icon
51
Crane NXT
CXT
$3.07B
$7.51M 0.56%
135,108
+28,848
+27% +$1.67M
CDNS icon
52
Cadence Design Systems
CDNS
$93.4B
$7.5M 0.56%
32,017
-157
-0.5% -$36.7K
PSN icon
53
Parsons
PSN
$5.08B
$7.12M 0.53%
130,985
-112
-0.1% -$5.93K
WFRD icon
54
Weatherford International
WFRD
$6.22B
$6.5M 0.49%
71,926
-194
-0.3% -$16.4K
SXI icon
55
Standex International
SXI
$4.12B
$6.2M 0.46%
42,581
+8,772
+26% +$1.31M
TDG icon
56
TransDigm Group
TDG
$67.7B
$6.12M 0.46%
7,263
– –
DSGX icon
57
Descartes Systems
DSGX
$6.82B
$6.07M 0.45%
82,713
-2,144
-3% -$162K
CLH icon
58
Clean Harbors
CLH
$16.3B
$5.91M 0.44%
35,297
+1,362
+4% +$230K
WAL icon
59
Western Alliance Bancorporation
WAL
$8.87B
$5.86M 0.44%
+127,508
New +$6.02M
APPF icon
60
AppFolio
APPF
$7.04B
$5.73M 0.43%
31,392
+6,969
+29% +$1.26M
TPH
61
DELISTED
Tri Pointe Homes
TPH
$5.72M 0.43%
209,035
-384
-0.2% -$11.8K
AAPL icon
62
Apple
AAPL
$4.57T
$5.57M 0.42%
32,547
+1,015
+3% +$186K
TREX icon
63
Trex
TREX
$5.01B
$5.53M 0.41%
89,804
+15,121
+20% +$1.04M
SG icon
64
Sweetgreen
SG
$642M
$5.41M 0.4%
+460,646
New +$6.41M
EXE
65
Expand Energy Corp
EXE
$21.5B
$5.3M 0.4%
61,500
– –
CCJ icon
66
Cameco
CCJ
$42.4B
$5.27M 0.39%
133,007
+11,058
+9% +$391K
RRX icon
67
Regal Rexnord
RRX
$11.9B
$4.95M 0.37%
34,654
-86
-0.2% -$13.2K
CFLT
68
DELISTED
Confluent
CFLT
$4.76M 0.36%
160,782
+17,354
+12% +$582K
BKR icon
69
Baker Hughes
BKR
$61.1B
$4.69M 0.35%
132,877
– –
JPM icon
70
JPMorgan Chase
JPM
$950B
$4.63M 0.35%
31,897
– –
BAH icon
71
Booz Allen Hamilton
BAH
$9.15B
$4.23M 0.32%
38,681
-181
-0.5% -$20.8K
FRSH icon
72
Freshworks
FRSH
$3.27B
$4.19M 0.31%
+210,163
New +$4.18M
AMD icon
73
Advanced Micro Devices
AMD
$789B
$4.16M 0.31%
40,459
-13,301
-25% -$1.44M
CR icon
74
Crane Co
CR
$12.7B
$4.15M 0.31%
46,747
-4,251
-8% -$378K
CXM icon
75
Sprinklr
CXM
$1.61B
$4.09M 0.31%
+295,782
New +$4.24M
1 2
3
4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Nicholas Investment Partners held 215 positions worth $1.34B, down 8.4% from $1.46B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Nicholas Investment Partners withdrew a net $153M in Q3 2023, closing 31 positions and reducing 51 holdings. Its most notable exit was Apellis Pharmaceuticals, an estimated $37.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 54% a quarter earlier, followed by Technology and Industrials.

Against the trend, Nicholas Investment Partners opened a new position in Sarepta Therapeutics worth $22.8M.

  • Nicholas Investment Partners's largest Q3 2023 buy was Sarepta Therapeutics: 188,085 shares worth $22.8M.
  • Nicholas Investment Partners added most to Immunocore in Q3 2023, an estimated $30.1M increase.
  • Nicholas Investment Partners's biggest Q3 2023 reduction was Karuna Therapeutics, Inc. Common Stock, cutting an estimated $12M.
  • Nicholas Investment Partners fully exited Apellis Pharmaceuticals in Q3 2023, selling an estimated $37.8M.
  • Nicholas Investment Partners's ten largest holdings make up 26% of its $1.34B portfolio in Q3 2023.
  • Nicholas Investment Partners opened 22 new positions and closed 31 in Q3 2023.
  • Nicholas Investment Partners's portfolio value fell 8.4% quarter-over-quarter to $1.34B.

Based on Nicholas Investment Partners's 13F filing for Q3 2023, filed 13 Nov 2023.